IL78197A - Nucleic acid encoding tgf-beta and its uses - Google Patents

Nucleic acid encoding tgf-beta and its uses

Info

Publication number
IL78197A
IL78197A IL78197A IL7819786A IL78197A IL 78197 A IL78197 A IL 78197A IL 78197 A IL78197 A IL 78197A IL 7819786 A IL7819786 A IL 7819786A IL 78197 A IL78197 A IL 78197A
Authority
IL
Israel
Prior art keywords
beta
nucleic acid
acid encoding
encoding tgf
tgf
Prior art date
Application number
IL78197A
Other languages
English (en)
Other versions
IL78197A0 (en
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL78197A0 publication Critical patent/IL78197A0/xx
Publication of IL78197A publication Critical patent/IL78197A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL78197A 1985-03-22 1986-03-19 Nucleic acid encoding tgf-beta and its uses IL78197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71514285A 1985-03-22 1985-03-22

Publications (2)

Publication Number Publication Date
IL78197A0 IL78197A0 (en) 1986-07-31
IL78197A true IL78197A (en) 1991-07-18

Family

ID=24872822

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78197A IL78197A (en) 1985-03-22 1986-03-19 Nucleic acid encoding tgf-beta and its uses

Country Status (7)

Country Link
EP (1) EP0200341B1 (de)
JP (2) JPH0659230B2 (de)
AT (1) ATE99737T1 (de)
DE (1) DE3689495T2 (de)
DK (1) DK175412B1 (de)
IE (1) IE61119B1 (de)
IL (1) IL78197A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
WO1988005787A1 (en) * 1987-01-30 1988-08-11 Techne Corporation Transforming growth factor-beta
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
EP0293785A3 (de) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
EP0418234B1 (de) * 1988-06-08 1994-03-23 Genentech, Inc. Nukleinsäure, die tgf-b3 kodiert, und ihre verwendung
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
CA2070393A1 (en) * 1989-10-18 1991-04-19 Charles M. Cohen Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
DE69726870T2 (de) * 1996-07-29 2004-10-28 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh EGF-ähnlicher Faktor von Chromaffingranula und von Gliazellen stammender neurotropher Faktor mit überlebensfördernder Aktivität auf dopaminerge Neuronen
GB9822682D0 (en) * 1998-10-16 1998-12-09 Gemini Research Limited Diagnostic method and apparatus based on polymorphism in a TGF-B-Gene
JP2002539172A (ja) 1999-03-17 2002-11-19 ノバルティス アクチエンゲゼルシャフト Tgf−ベータを含む医薬組成物
US7211271B2 (en) 2001-03-12 2007-05-01 The Regents Of The University Of California Method to improve hydroxyapatite implantation and stimulate bone regeneration
EP1740615B1 (de) 2004-03-31 2014-11-05 Genentech, Inc. Humanisierte anti-tgf-beta-antikörper
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
KR20090105913A (ko) 2006-11-02 2009-10-07 다니엘 제이 카폰 이동 부분을 갖는 하이브리드 면역글로불린
JP7125933B2 (ja) * 2017-05-02 2022-08-25 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587022T2 (de) * 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.

Also Published As

Publication number Publication date
IE860743L (en) 1986-09-22
DE3689495D1 (de) 1994-02-17
DK175412B1 (da) 2004-09-27
JPH0659230B2 (ja) 1994-08-10
JPS61219395A (ja) 1986-09-29
JPH0763378B2 (ja) 1995-07-12
IE61119B1 (en) 1994-10-05
EP0200341B1 (de) 1994-01-05
EP0200341A1 (de) 1986-11-05
DK127786D0 (da) 1986-03-20
ATE99737T1 (de) 1994-01-15
DE3689495T2 (de) 1994-06-01
IL78197A0 (en) 1986-07-31
DK127786A (da) 1986-09-23
JPH06169777A (ja) 1994-06-21

Similar Documents

Publication Publication Date Title
IL78197A (en) Nucleic acid encoding tgf-beta and its uses
AU6329694A (en) Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase
EP0244234A3 (en) Transformation of trichoderma
IL74909A (en) Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
AU561343B2 (en) Human immune interferon by recombinant dna
OA08947A (en) Mammalian interleukin-4.
DK170186A (da) Biologisk ren kultur af en stamme lactobacillus acidophilus samt fremgangsmaade til isolering af en saadan kultur og anvendelse af denne somlaegemiddel
HUT42131A (en) Vectors for the expression and secretion of hirudine in transformed yeasts
EP0251037A3 (en) Novel human tnf polypeptide mutants and dnas encoding said mutants
DK1396542T3 (da) P-selectin ligand protein
DE3688671D1 (de) Menschliches interferon-beta2a vektoren, die gene enthalten, die fuer das genannte interferon kodieren zellinien, die dieses produzieren und verwendung des genannten interferons als pharmazeutikum.
ES8107307A1 (es) Un procedimiento de preparacion de un vector de transferen- cia de adn
GB2191491B (en) Dna segment coding for a specific lipase, vectors for the expression thereof, microorganisms transformed by these vectors and use of these microorganisms for
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
IL82736A0 (en) Composite dna sequence,vectors,cells and bacterial strains comprising it and their use for the production of growth hormone
DE69119461D1 (de) Strukturgen von membrangebundenem Alkoholdehydrogenase-Komplex, Plasmid, das dieses Gen enthält und transformierte Essigsäurebakterien
Raab Treatment of psoriasis with fumaric acid and fumarates.
ATE63135T1 (de) Transformationsvektoren fuer mikroorganismen mit guenstiger rhizospherischer wirkung, transformierte staemme und landwirtschaftliche verwendung.
LV5677A3 (lv) Bakteriju lactobacillus casei var. alactosus celms - L(+)-pienskabes producents izmantojams lopbaribas konservesanai
Bai Determination of the adsorption behaviour of OPD H species in the cathodic hydrogen evolution reaction.
BG52048Y2 (en) Fermenter for microorganism and eukaryotic cell cultivation

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed